Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,275.00
Bid: 1,286.00
Ask: 1,290.00
Change: -23.00 (-1.77%)
Spread: 4.00 (0.311%)
Open: 1,293.00
High: 1,304.00
Low: 1,275.00
Prev. Close: 1,298.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement Director/PDMR Shareholding

18 Mar 2024 17:14

RNS Number : 3043H
Indivior PLC
18 March 2024
 

INDIVIOR PLC (THE 'COMPANY')

CORRECTION - NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

Correction made to the announcement made earlier today at 16:17:57 (RNS No 2961H) on 18 March 2024. The original announcement included an incorrect shareholding in respect of the number of shares held by Mr Crossley following completion of the transactions. Following these transactions, Mr Crossley holds 90,032 shares.

All other details regarding the transactions in the announcement remain unchanged.

The amended announcement is set out in full below:

The Company announces the following transactions carried out by Mark Crossley, a PDMR and the Chief Executive of the Company on March 14, 2024, and March 15, 2024.

On March 15, 2024, an award over 19,215 Ordinary Shares of $0.10 each ('Shares') vested in favour of Mark under the Indivior Deferred Bonus Plan 2018 (the 'DBP'). This award was granted on March 15, 2022 and vested following the end of the two-year deferral period. The vesting of the award was not subject to performance conditions. The vesting of this award was settled on a net-settled basis, resulting in the delivery of Shares in the amount set out below.

Name of PDMR

Number of vested Shares

Number of Shares delivered

Mark Crossley

19,215

10,549

 

On March 15, 2024, Mark also received 15,444 Shares, following the exercise and net settlement of a share option. The option exercise was in respect of an option over 42,123 Shares granted on December 29, 2014, at an option price of £5.55 per share.

On March 14, 2024, March 15, 2024 and March 18, 2024, Mark Crossley disposed of a total of 117,197 Shares; 25,993 Shares arising from the above transactions and 91,204 Shares from the release of vested awards under the Indivior Long-Term Incentive Plan on March 5, 2024.

91,204 Shares were sold on March 14, 2024 at an average price of £16.30 per share. 15,444 Shares were sold on March 15, 2024 at an average price of £16.44 per share and 10,549 Shares were sold on March 18, 2024 at an average price of £16.17 per share. 

 

Following the completion of these transactions, Mark Crossley has an interest in 90,032 Shares in the Company.

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Mark Crossley

2

 

Reason for the notification

 

a)

 

Position/status

  

Director / PDMR - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Indivior PLC

b)

 

LEI

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Delivery of Shares on Vesting of an award granted under the DBP.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

10,549

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 15, 2024

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Delivery of Shares arising from exercise of an option

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£5.55

15,444

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 15, 2024

f)

 

Place of the transaction

 

Outside a trading venue

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£16.30

91,204

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 14, 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£16.44

15,444

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 15, 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£16.17

10,549

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 18, 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJPMRTMTMBBPI
Date   Source Headline
2nd Dec 20197:00 amRNSNew SUBLOCADE outcomes analysis published in JSAT
12th Nov 20197:00 amRNSIndivior Launches National DTC Campaign in US
11th Nov 20198:46 amRNSBlock listing Interim Review
6th Nov 20194:08 pmRNSHolding(s) in Company
4th Nov 20193:42 pmRNSIndivior To Participate In Upcoming Conferences
31st Oct 20192:30 pmRNSBoard Committee Changes
31st Oct 201911:00 amRNS3rd Quarter Results
16th Oct 20199:30 amRNSDirectorate Change
15th Oct 20197:00 amRNSIndivior Raises FY 2019 Guidance
3rd Oct 20197:00 amRNSHolding(s) in Company
1st Oct 20197:00 amRNSNotice of Results
1st Oct 20197:00 amRNSTotal Voting Rights
27th Sep 20198:00 amRNSIndivior Receives US NIH Grant Award
27th Sep 20197:00 amRNSHolding(s) in Company
2nd Sep 201910:58 amRNSTotal Voting Rights
13th Aug 20192:30 pmRNSDirector/PDMR Shareholding
9th Aug 20197:00 amRNSDirector/PDMR Shareholding
8th Aug 20192:30 pmRNSDirector/PDMR Shareholding
6th Aug 20192:00 pmRNSDirector/PDMR Shareholding
1st Aug 20193:37 pmRNSHolding(s) in Company
1st Aug 20199:46 amRNSTotal Voting Rights
31st Jul 20197:01 amRNSDirectorate Changes
31st Jul 20197:00 amRNSHalf-year Report
30th Jul 201910:21 amRNSHolding(s) in Company
29th Jul 20192:00 pmRNSDirector's Change of Responsibilities
25th Jul 20194:52 pmRNSHolding(s) in Company
25th Jul 20194:00 pmRNSHolding(s) in Company
15th Jul 20192:40 pmRNSCourt of Appeals Rules on Indivior Patents
11th Jul 20191:18 pmRNSIndivior Provides Statement on RB Settlement
11th Jul 20197:00 amRNSIndivior PLC Raises FY 2019 Guidance
8th Jul 201912:00 pmRNSAdditional Listing
5th Jul 20198:23 amRNSHolding(s) in Company
3rd Jul 20197:00 amRNSNotice of Results
1st Jul 20197:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 201912:31 pmRNSIndivior Presents RECOVER Study Data at CPDD 2019
14th Jun 20198:47 amRNSHolding(s) in Company
29th May 20197:00 amRNSHolding(s) in Company
24th May 20199:04 amRNSHolding(s) in Company
17th May 20199:55 amRNSHolding(s) in Company
16th May 20197:00 amRNSIndivior to Participate in Conference
15th May 20197:00 amRNSDirector/PDMR Shareholding
13th May 20193:43 pmRNSDirector/PDMR Shareholding
13th May 20197:00 amRNSHolding(s) in Company
13th May 20197:00 amRNSHolding(s) in Company
9th May 201911:30 amRNSLicensing of PERSERIS in Canada
9th May 201910:29 amRNSBlock listing Interim Review
8th May 20191:54 pmRNSResult of AGM
3rd May 20197:00 amRNSHolding(s) in Company
2nd May 201912:00 pmRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.